Not logged in
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
SaveFirst results from phase I/II study of CTS2190, a novel small-molecule inhibitor of type I PRMTs, in patients with advanced solid tumors
Cheng, X.; Song, Z.; Yao, J.; Yang, J.; Wang, M.; Zhou, H.; Sun, T.; Wang, Q.; Wu, L.; Miao, J.; Mi, Y.; Lin, J.; Zhao, H.; Xing, S.; Wu, H.
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save